ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction

作者: Piero Pollesello , Alexandre Mebazaa

DOI: 10.1097/01.CCX.0000145099.20822.19

关键词:

摘要: Purpose of reviewThe aim this review is to highlight the most recent and interesting articles on physiologic properties functions ATP-dependent potassium channels in cardiovascular system role channel openers for treatment dysfuncti

参考文章(76)
Takayoshi Tsutamoto, Masahiko Kinoshita, Tomoko Hisanaga, Yukiharu Maeda, Keiko Maeda, Atsuyuki Wada, Daisuke Fukai, Shintaro Yoshida, Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure American Journal of Cardiology. ,vol. 75, pp. 1162- 1165 ,(1995) , 10.1016/S0002-9149(99)80750-4
Brian O’Rourke, Evidence for Mitochondrial K+ Channels and Their Role in Cardioprotection Circulation Research. ,vol. 94, pp. 420- 432 ,(2004) , 10.1161/01.RES.0000117583.66950.43
Steffen Sonntag, Stig Sundberg, Lasse Antero Lehtonen, Franz Xaver Kleber, The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. Journal of the American College of Cardiology. ,vol. 43, pp. 2177- 2182 ,(2004) , 10.1016/J.JACC.2004.02.052
Peter S. Fischbach, Andrew White, Terrance D. Barrett, Benedict R. Lucchesi, Risk of Ventricular Proarrhythmia with Selective Opening of the Myocardial Sarcolemmal versus Mitochondrial ATP-Gated Potassium Channel Journal of Pharmacology and Experimental Therapeutics. ,vol. 309, pp. 554- 559 ,(2004) , 10.1124/JPET.103.060780
Raimund Mannhold, KATP channel openers: structure-activity relationships and therapeutic potential. Medicinal Research Reviews. ,vol. 24, pp. 213- 266 ,(2004) , 10.1002/MED.10060
F Follath, JGF Cleland, H Just, JGY Papp, H Scholz, K Peuhkurinen, VP Harjola, V Mitrovic, M Abdalla, E-P Sandell, L Lehtonen, Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial* The Lancet. ,vol. 360, pp. 196- 202 ,(2002) , 10.1016/S0140-6736(02)09455-2
Dalia M Kopustinskiene, Piero Pollesello, Nils-Erik L Saris, Levosimendan is a mitochondrial KATP channel opener European Journal of Pharmacology. ,vol. 428, pp. 311- 314 ,(2001) , 10.1016/S0014-2999(01)01350-4